July 24, 2014
U.S. Court Decision Allowing Antibiotics in Animal Feed Puts Public Health at Risk
Johns Hopkins Public Health and Food Production Expert Available to Comment
Today, the U.S. Second Circuit Court of Appeals denied an appeal that would require the Food and Drug Administration (FDA) to end the use of penicillin and tetracyclines in animal feed unless drug manufacturers can prove such use is safe. The decision was made despite overwhelming scientific evidence linking the continued misuse of antibiotics in food animals to rising antibiotic resistance in humans.
Keeve Nachman, PhD, a food production and public health researcher at the Johns Hopkins Center for a Livable Future, is available to comment on the decision by the U.S. Court, which he calls is a tremendous disappointment and a setback for public health. Studies show that the practice of feeding antibiotics to animals for purposes other than treating or controlling disease unnecessarily contributes to the development of bacteria that are resistant to drugs, such as penicillin and tetratcyclines, used for treating common infections in humans.
“Penicillin and tetracyclines are necessary and commonly-prescribed antibiotics used to treat a variety of infections in people. If they lose their effectiveness, many infections that used to be easily treatable will become far more dangerous and costly to treat,” said Nachman.
Keeve E. Nachman, PhD, MHS, directs the Food Production & Public Health program at the Johns Hopkins Center for a Livable Future and is on the faculty of the Johns Hopkins Bloomberg School of Public Health. An expert on the public health and environmental impacts of industrial agriculture, Nachman’s research centers on the human health risks posed by drugs used in food animal production, including antibiotics and arsenicals.
Johns Hopkins Center for a Livable Future media contact: Natalie Wood-Wright at 443-824-1371 or firstname.lastname@example.org.
Johns Hopkins Bloomberg School of Public Health media contact: Barbara Benham at 410-614-6029 or email@example.com.